Library — CHDR

Search

Filter

Evaluation of a bedside device to assess the activated partial thromboplastin time for heparin monitoring in infants.

Klein RH, van der Vorst MM, de Wilde RB, Hogenbirk K, de Kam ML, Burggraaf J

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2013 Mar; 24(3):327-31

View publication
Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives: a rebuttal.

Kluft C, Skouby SO, Jespersen J, Burggraaf J

Journal of thrombosis and haemostasis : JTH, 2013 Jan; 11(2):394-5

View publication
Increased impact of a contraceptive vaginal ring with ethinyl estradiol and nestorone on C-reactive protein.

Rad M, Burggraaf J, Sitruk-Ware RL, de Kam ML, Cohen AF, Kluft C

Steroids, 2012 Oct; 77(13):1483-6

View publication
Modulation of vasoactivity and platelet aggregation by selective 5-HT receptor antagonism in humans.

Moerland M, Kemme M, Dijkmans A, Bergougnan L, Burggraaf J

Journal of cardiovascular pharmacology, 2011 Nov; 58(6):575-80

View publication
Introduction to haemostasis from a pharmacodynamic perspective.

Kluft C, Burggraaf J

British journal of clinical pharmacology, 2011 Sep; 72(4):538-46

View publication
A phase I, single and fractionated, ascending-dose study evaluating the safety, pharmacokinetics, pharmacodynamics, and immunogenicity of an erythropoietin mimetic antibody fusion protein (CNTO 528) in healthy male subjects.

Bouman-Thio E, Franson K, Miller B, Getsy J, Cohen A, Bai SA, Yohrling J, Frederick B, Marciniak S, Jiao Q, Jang H, Davis H, Burggraaf J

Journal of clinical pharmacology, 2008 Oct; 48(10):1197-207

View publication
Pharmacodynamics and pharmacokinetics of the novel thrombopoietin mimetic peptide RWJ-800088 in humans.

Liem-Moolenaar M, Cerneus D, Molloy CJ, End D, Brown KH, de Kam ML, Cohen AF, van Hensbergen Y, Burggraaf J

Clinical pharmacology and therapeutics, 2008 Sep; 84(4):481-7

View publication
Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.

Sitruk-Ware RL, Menard J, Rad M, Burggraaf J, de Kam ML, Tokay BA, Sivin I, Kluft C

Contraception, 2007 May; 75(6):430-7

View publication
Pharmacokinetics and systemic endocrine effects of the phyto-oestrogen 8-prenylnaringenin after single oral doses to postmenopausal women.

Rad M, Hümpel M, Schaefer O, Schoemaker RC, Schleuning WD, Cohen AF, Burggraaf J

British journal of clinical pharmacology, 2006 Aug; 62(3):288-96

View publication

«
1
2
3
4
5
6
»